NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells

Autor Di Matteo, P, Hackl, C, Jedeszko, C, Valentinis, B, Bordignon, C, Traversari, C, Kerbel, R S, Rizzardi, G-P
Vydáno 2013

Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial

Autor Walter, I., Schulz, U., Vogelhuber, M., Wiedmann, K., Endlicher, E., Klebl, F., Andreesen, R., Herr, W., Ghibelli, L., Hackl, C., Wiest, R., Reichle, A.
Vydáno v Med Oncol (2017)